Genome Editing Stocks List

Recent Signals

Date Stock Signal Type
2019-08-22 ABEO New 52 Week Closing Low Bearish
2019-08-22 ABEO New 52 Week Low Weakness
2019-08-22 ABEO Reversal New Lows Setup Bearish Swing Setup
2019-08-22 CRSP NR7 Range Contraction
2019-08-22 CRSP Fell Below 20 DMA Bearish
2019-08-22 DTIL New 52 Week Closing Low Bearish
2019-08-22 DTIL Stochastic Reached Oversold Weakness
2019-08-22 EDIT 20 DMA Support Bullish
2019-08-22 EDIT Bollinger Band Squeeze Range Contraction
2019-08-22 NTLA Non-ADX 1,2,3,4 Bullish Bullish Swing Setup

Genome editing, or genome engineering, is a type of genetic engineering in which DNA is inserted, deleted, modified or replaced in the genome of a living organism. Unlike early genetic engineering techniques that randomly inserts genetic material into a host genome, genome editing targets the insertions to site specific locations.
In 2018, the common methods for such editing use engineered nucleases, or "molecular scissors". These nucleases create site-specific double-strand breaks (DSBs) at desired locations in the genome. The induced double-strand breaks are repaired through nonhomologous end-joining (NHEJ) or homologous recombination (HR), resulting in targeted mutations ('edits').
As of 2015 four families of engineered nucleases were used: meganucleases, zinc finger nucleases (ZFNs), transcription activator-like effector-based nucleases (TALEN), and the clustered regularly interspaced short palindromic repeats (CRISPR/Cas9) system. Nine genome editors were available as of 2017.Genome editing with engineered nucleases, i.e. all three major classes of these enzymes—zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs) and engineered meganucleases—were selected by Nature Methods as the 2011 Method of the Year. The CRISPR-Cas system was selected by Science as 2015 Breakthrough of the Year.

More about Genome Editing